HighVista Strategies’s Pfizer PFE Stock Holding History

HighVista Strategies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-60,300	Closed	-$1.69M	–	161
2024 Q2	$1.69M	Buy	+60,300	New	+$1.66M	0.62%	56
2019 Q1	–	Sell	-6,324	Closed	-$262K	–	146
2018 Q4	$262K	Sell	6,324 -5,059	-44%	-$210K	0.23%	79
2018 Q3	$476K	Buy	11,383 +1,370	+14%	+$52.7K	0.22%	75
2018 Q2	$345K	Sell	10,013 -211	-2%	-$7.21K	0.16%	87
2018 Q1	$344K	Sell	10,224 -527	-5%	-$18.1K	0.15%	101
2017 Q4	$369K	Sell	10,751 -4,110	-28%	-$140K	0.1%	153
2017 Q3	$503K	Buy	+14,861	New	+$478K	0.11%	129
2016 Q3	–	Sell	-98,233	Closed	-$3.28M	–	192
2016 Q2	$3.28M	Buy	+98,233	New	+$3.14M	0.63%	43
2015 Q1	–	Sell	-9,987	Closed	-$295K	–	199
2014 Q4	$295K	Buy	+9,987	New	+$286K	0.04%	130
2014 Q2	–	Sell	-8,055	Closed	-$223K	–	167
2014 Q1	$223K	Buy	+8,055	New	+$240K	0.03%	139
2013 Q4	–	Sell	-292,931	Closed	-$7.98M	–	147
2013 Q3	$7.98M	Buy	+292,931	New	+$7.97M	1.57%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

HighVista Strategies's PFE Position: Q3 2024 in Review

HighVista Strategies sold out of Pfizer (PFE) in Q3 2024, closing a stake of 60,300 shares — an estimated $1.69M sold.

HighVista Strategies first reported a position in PFE in Q3 2013 and held it in 11 quarters. The position peaked at $7.98M in Q3 2013. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

HighVista Strategies reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
HighVista Strategies sold 60,300 Pfizer shares in Q3 2024, an estimated $1.69M.
HighVista Strategies first reported a position in Pfizer in Q3 2013 and held it in 11 quarters.
HighVista Strategies's Pfizer position peaked at $7.98M in Q3 2013.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on HighVista Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.